Jio Platforms vs Paras Healthcare IPO: Which Should You Apply To?

Jio Platforms and Paras Healthcare are both set to close their IPOs on October 23, 2026. As retail investors consider how to allocate their funds, a comparison of these two offerings can provide clarity.

Side-by-Side Comparison

GMP Comparison

Jio Platforms shows a strong grey market premium (GMP) of ₹250, translating to approximately 22.34%. In contrast, Paras Healthcare has a much lower GMP of ₹11, or about 1.59%. This significant difference in GMP indicates stronger market sentiment towards Jio Platforms.

Subscription Demand

Subscription data reveals that Jio Platforms has garnered substantial interest, with a total subscription of 21.36 times as of October 23, 2026. Notably, the Qualified Institutional Buyers (QIB) segment saw a remarkable subscription of 67.15 times. In comparison, Paras Healthcare has a total subscription of only 2.34 times, with the QIB segment at 3.25 times. This stark contrast in demand may influence investor decisions.

Sector Analysis

Jio Platforms operates in the telecom sector, providing a range of digital connectivity and technology services, which are essential in today's digital age. The company serves over 524 million customers and offers diverse services, including mobile, broadband, and enterprise solutions. On the other hand, Paras Healthcare is positioned in the hospital sector, operating a network of hospitals primarily in North India. While healthcare is a vital sector, the growth potential may differ compared to the rapidly evolving telecom industry.

Issue Size

The issue size for Jio Platforms is substantially larger at ₹30,213 crore, compared to Paras Healthcare's ₹1,450 crore. This difference in scale may reflect the varying business models and growth trajectories of the two companies.

Business Fundamentals

Jio Platforms has a robust business model with a diverse portfolio, including services for both consumers and enterprises, which enhances its revenue streams. Conversely, Paras Healthcare, while established, operates a smaller network of hospitals and may face challenges in scaling its operations compared to Jio Platforms.

Disclaimer: This is an objective comparison of publicly available IPO data, not investment advice or a personal recommendation to apply for any specific IPO. GMP is unofficial and unregulated. TopFund is not a SEBI-registered investment adviser — please do your own research or consult a qualified adviser before applying.